Biotech, bite-sized — UK science, explained fast
Cultivated meat is moving from lab demo to regulatory checklist. Here’s what the FSA’s 2026 authorisation route asks for, where labelling could get messy, and why the bioreactor—not the bun—is the real bottleneck.
Before a UK cell-or-gene therapy batch can reach a patient, a Qualified Person has to put their name to it. Here is what that signature actually covers, why small ATMP manufacturers feel the squeeze, and how early-career scientists can make release week less painful.
A catalogue number can get an antibody onto a purchase order, but it cannot tell you whether the band is real. This 2026 walkthrough gives UK students and lab managers a practical due-diligence routine for RRIDs, knockout controls, core-facility help and the questions worth asking before a vial earns freezer space or a figure panel.
Joining animal-based research as a UK student? The project licence is not background admin — it sets the limits on what can be done and by whom. This short checklist helps you ask better questions before your first protocol day.
When a gene-editing therapy moves from trial data into an NHS pathway, patients and carers need plainer answers than a press release can give. This audit sets out what MHRA authorisation, NICE appraisal and long-term follow-up actually mean, with a checklist for reading the next UK announcement.
A £50K benchtop sequencer can look like a bargain until the service contract, flow cells and storage bill arrive. This practical UK buying guide walks through the questions academic labs and early-stage biotech teams should ask before signing a three-year deal.
Most containment failures start as administrative gaps, not dramatic accidents. This short audit checks the notification, risk assessment, GM safety committee sign-off and waste trail before a CRISPR experiment begins.
Biobank consent forms are not paperwork to skim on the way to the freezer. This practical audit treats consent language like a protocol: version checks, permitted uses, withdrawal routes and the questions to settle before any human sample is thawed.
Bacteriophage therapy is moving from dramatic case reports into UK clinical studies, but the evidence base is still uneven. Here’s a plain-English guide to what phage therapy is, where UK research is happening, and how students can tell a promising trial from a compelling anecdote.
Biofoundries are the UK’s shared labs for synthetic biology, but access can feel mysterious. This practical guide profiles five facilities, explains how booking and training usually work, and suggests a beginner-friendly project for each.
Ultra-low freezers are quietly becoming a capacity, cost and compliance bottleneck for UK labs and spinouts. Here is a practical cold-chain audit you can run in an afternoon, plus the shared-freezer and biobanking trade-offs worth knowing in 2026.
Reproducibility red flags usually look mundane: a vague protocol, a pipette with no calibration sticker, decorative controls or reagent maths that is too tidy. This field guide gives UK students and early-career researchers a one-session audit to catch them early.
UK labs have plenty of sustainability pledges but very little honest accounting for gloves, pipette tips and culture flasks. This opinion-led deep dive maps the take-back schemes, procurement barriers and university pilots, then argues for a simpler waste ledger in 2026.
AI protein-structure tools are now standard coursework kit in UK life-science departments, but a polished ribbon diagram can hide weak regions, stale templates and training-data bias. Here is a fast, practical audit routine students can run before citing a model or building on it.
Microfluidics has a habit of looking brilliant on a conference slide and fragile on a hospital bench. We picked five UK university spinouts — from Cambridge to Glasgow — and separated the near-clinical tools from the lab demos, with notes on funding, NHS adoption and the regulatory bends ahead.
The UK's Precision Breeding Act is often reduced to a culture-war soundbite. In practice, it is a regulatory pathway — with field trials, safety checks and a public register. We use a lower-acrylamide wheat as a case study to show what changes on the farm and in the shop.